City of Hope

City of Hope, a NCI-designated Comprehensive Cancer Center

Page Title

Skip Navigation

Global Navigation

Border Border
The following is a list of available studies directed by  Nayana Vora, MD  
Search results:  2  Clinical trial(s) found  (Page 1 of 1 )
Results per page: 25 50 100 All 1-2 Trials Jump to page:

COH Protocol Number: 14258 Number: NCT02135042

Principal Investigator: Nayana Vora, MD
Sponsor: Cooperative Group

Title:  NRG Oncology NRG-HN001: Randomized Phase II and Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA)

COH Protocol Number: 12447 Number: NCT01644669

Principal Investigator: Nayana Vora, MD
Sponsor: Industrial

Title:  A Safety and Efficacy Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft Axxent eBx System at the Time of Breast Conservation Surgery for Early Stage Breast Cancer

Results per page: 25 50 100 All 1-2 Trials Jump to page:

NCI CCC LogoCity of Hope, An NCI-designated Comprehensive Cancer Center, is an innovative biomedical research, treatment and educational institution dedicated to the prevention and cure of cancer and other life-threatening illness.
Best Of logoCity of Hope has been named one of "America's Best Hospitals" in cancer and gynecology by U.S. News & World Report. Read more here...
NCI CCC LogoThe National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HONcode of the Healthcare on the Net Foundation.